Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1854 1
1885 2
1893 1
1906 1
1911 1
1915 1
1916 1
1918 1
1919 1
1920 2
1921 5
1922 4
1923 2
1926 1
1927 1
1930 1
1931 1
1932 2
1933 2
1934 2
1935 1
1936 2
1937 2
1938 5
1939 1
1940 1
1944 2
1946 10
1947 4
1948 4
1949 12
1950 14
1951 12
1952 7
1953 9
1954 10
1955 7
1956 15
1957 18
1958 12
1959 12
1960 13
1961 11
1962 10
1963 6
1964 14
1965 15
1966 21
1967 22
1968 25
1969 28
1970 41
1971 35
1972 48
1973 50
1974 40
1975 35
1976 42
1977 51
1978 34
1979 59
1980 43
1981 48
1982 41
1983 54
1984 58
1985 57
1986 73
1987 80
1988 66
1989 68
1990 97
1991 94
1992 94
1993 102
1994 115
1995 131
1996 96
1997 115
1998 105
1999 98
2000 98
2001 117
2002 127
2003 133
2004 118
2005 126
2006 146
2007 159
2008 142
2009 164
2010 153
2011 165
2012 189
2013 176
2014 208
2015 184
2016 195
2017 253
2018 243
2019 218
2020 223
2021 247
2022 204
2023 286
2024 222
2025 186

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,585 results

Results by year

Filters applied: . Clear all
Page 1
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial.
Thieblemont C, Phillips T, Ghesquieres H, Cheah CY, Clausen MR, Cunningham D, Do YR, Feldman T, Gasiorowski R, Jurczak W, Kim TM, Lewis DJ, van der Poel M, Poon ML, Cota Stirner M, Kilavuz N, Chiu C, Chen M, Sacchi M, Elliott B, Ahmadi T, Hutchings M, Lugtenburg PJ. Thieblemont C, et al. Among authors: lewis dj. J Clin Oncol. 2023 Apr 20;41(12):2238-2247. doi: 10.1200/JCO.22.01725. Epub 2022 Dec 22. J Clin Oncol. 2023. PMID: 36548927 Free PMC article. Clinical Trial.
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma.
Wang ML, Jurczak W, Zinzani PL, Eyre TA, Cheah CY, Ujjani CS, Koh Y, Izutsu K, Gerson JN, Flinn I, Tessoulin B, Alencar AJ, Ma S, Lewis D, Lech-Maranda E, Rhodes J, Patel K, Maddocks K, Lamanna N, Wang Y, Tam CS, Munir T, Nagai H, Hernandez-Ilizaliturri F, Kumar A, Fenske TS, Seymour JF, Zelenetz AD, Nair B, Tsai DE, Balbas M, Walgren RA, Abada P, Wang C, Zhao J, Mato AR, Shah NN. Wang ML, et al. Among authors: lewis d. J Clin Oncol. 2023 Aug 20;41(24):3988-3997. doi: 10.1200/JCO.23.00562. Epub 2023 May 16. J Clin Oncol. 2023. PMID: 37192437 Free PMC article.
Hearing loss: diagnosis and management.
Lasak JM, Allen P, McVay T, Lewis D. Lasak JM, et al. Among authors: lewis d. Prim Care. 2014 Mar;41(1):19-31. doi: 10.1016/j.pop.2013.10.003. Epub 2013 Nov 18. Prim Care. 2014. PMID: 24439878 Review.
Myalgic encephalomyelitis: International Consensus Criteria.
Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, Staines D, Powles AC, Speight N, Vallings R, Bateman L, Baumgarten-Austrheim B, Bell DS, Carlo-Stella N, Chia J, Darragh A, Jo D, Lewis D, Light AR, Marshall-Gradisnik S, Mena I, Mikovits JA, Miwa K, Murovska M, Pall ML, Stevens S. Carruthers BM, et al. Among authors: lewis d. J Intern Med. 2011 Oct;270(4):327-38. doi: 10.1111/j.1365-2796.2011.02428.x. Epub 2011 Aug 22. J Intern Med. 2011. PMID: 21777306 Free PMC article. Review.
Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial.
Brody JD, Jørgensen J, Belada D, Costello R, Trněný M, Vitolo U, Lewis DJ, Karimi YH, Sureda A, André M, Wahlin BE, Lugtenburg PJ, Jiang T, Karagoz K, Steele AJ, Abbas A, Wang L, Risum M, Cordoba R. Brody JD, et al. Among authors: lewis dj. Blood. 2025 Apr 10;145(15):1621-1631. doi: 10.1182/blood.2024026830. Blood. 2025. PMID: 39792928 Free PMC article. Clinical Trial.
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
Wang ML, Jurczak W, Jerkeman M, Trotman J, Zinzani PL, Belada D, Boccomini C, Flinn IW, Giri P, Goy A, Hamlin PA, Hermine O, Hernández-Rivas JÁ, Hong X, Kim SJ, Lewis D, Mishima Y, Özcan M, Perini GF, Pocock C, Song Y, Spurgeon SE, Storring JM, Walewski J, Zhu J, Qin R, Henninger T, Deshpande S, Howes A, Le Gouill S, Dreyling M; SHINE Investigators. Wang ML, et al. Among authors: lewis d. N Engl J Med. 2022 Jun 30;386(26):2482-2494. doi: 10.1056/NEJMoa2201817. Epub 2022 Jun 3. N Engl J Med. 2022. PMID: 35657079 Clinical Trial.
Safeguarding children a priority.
Lewis D. Lewis D. Arch Dis Child Educ Pract Ed. 2023 Dec;108(6):392-393. doi: 10.1136/archdischild-2023-326307. Epub 2023 Oct 27. Arch Dis Child Educ Pract Ed. 2023. PMID: 37890979 No abstract available.
Merkel Cell Carcinoma.
Lewis DJ, Sobanko JF, Etzkorn JR, Shin TM, Giordano CN, McMurray SL, Walker JL, Zhang J, Miller CJ, Higgins HW 2nd. Lewis DJ, et al. Dermatol Clin. 2023 Jan;41(1):101-115. doi: 10.1016/j.det.2022.07.015. Epub 2022 Oct 28. Dermatol Clin. 2023. PMID: 36410971 Review.
Human-correlated genetic models identify precision therapy for liver cancer.
Müller M, May S, Hall H, Kendall TJ, McGarry L, Blukacz L, Nuciforo S, Georgakopoulou A, Jamieson T, Phinichkusolchit N, Dhayade S, Suzuki T, Huguet-Pradell J, Powley IR, Officer-Jones L, Pennie RL, Esteban-Fabró R, Gris-Oliver A, Pinyol R, Skalka GL, Leslie J, Hoare M, Sprangers J, Malviya G, Mackintosh A, Johnson E, McCain M, Halpin J, Kiourtis C, Nixon C, Clark G, Clark W, Shaw R, Hedley A, Drake TM, Tan EH, Neilson M, Murphy DJ, Lewis DY, Reeves HL, Le Quesne J, Mann DA, Carlin LM, Blyth K, Llovet JM, Heim MH, Sansom OJ, Miller CJ, Bird TG. Müller M, et al. Among authors: lewis dy. Nature. 2025 Mar;639(8055):754-764. doi: 10.1038/s41586-025-08585-z. Epub 2025 Feb 19. Nature. 2025. PMID: 39972137 Free PMC article.
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
Meyerhardt JA, Shi Q, Fuchs CS, Meyer J, Niedzwiecki D, Zemla T, Kumthekar P, Guthrie KA, Couture F, Kuebler P, Bendell JC, Kumar P, Lewis D, Tan B, Bertagnolli M, Grothey A, Hochster HS, Goldberg RM, Venook A, Blanke C, O'Reilly EM, Shields AF. Meyerhardt JA, et al. Among authors: lewis d. JAMA. 2021 Apr 6;325(13):1277-1286. doi: 10.1001/jama.2021.2454. JAMA. 2021. PMID: 33821899 Free PMC article. Clinical Trial.
6,585 results